Research evaluation, strategy and priorities
Arthritis Australia has a 40 year history of research funding and partnership. Periodic evaluation and review of our research activities is an important way of ensuring that the research we fund, commission and partner on delivers outcomes for people with arthritis and musculoskeletal conditions, and meets our objective of nurturing the next generation of researchers.
Key reports that we have commissioned on our research outcomes and strategy are below:
Evaluation of Preferred Investment Models for Arthritis and Musculoskeletal Research
Evaluation of Preferred Investment Models for Arthritis and Musculoskeletal Research
This report builds on our previous body of work to define a clear, stakeholder-endorsed model for government investment in arthritis and musculoskeletal research.
Impactful Arthritis Research
Understanding the arthritis research landscape
In 2022 we commissioned Research Australia to map the Australian research landscape, and understand the gaps and priorities
What consumers want
The second part of our project with Research Australia identifies the unmet need of Australians living with arthritis
Impactful arthritis research
The final report from Research Australia presents recommendations to guide future investment that is of value to consumers, demonstrates sector leadership and provides advocacy targets and options for co-investment with government philanthropy
Researching our Research
Researching our Research
The Researching our Research report represents the first in-depth evaluation of the impacts of Arthritis Australia’s research funding from 2006-2011